Valuation check: SEPN's profit margin is -49.88%, below the Healthcare sector average of 15.29%.
Get informed when a big investor buys or sells
+ FollowAs of Mar 2026
Trailing 12 months ending Mar 2026
The latest profit margin for SEPN is -49.88% as of March 2026. That compares with -3830.76% in the prior-year period — up 98.7% year over year. That is below the Healthcare sector average of 15.29%. Investors often review this figure alongside Septerna's historical trend and sector peers before judging valuation or financial health.
Over the past year, SEPN's profit margin moved from -3830.76% to -49.88% — a 98.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Septerna's valuation or profitability profile.
Against Healthcare companies, SEPN currently prints -49.88% for profit margin, while the sector average sits near 15.29%. That is roughly 426.2% below the sector mean. Large gaps often invite a closer look at Septerna's growth, margins, and balance sheet.
Profit Margin shows how effectively Septerna converts resources into returns. At -49.88%, SEPN may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -3830.76% in the prior-year period — up 98.7% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting SEPN's profit margin (-49.88%), review year-over-year change from -3830.76%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.